HLB Pharmaceutical Co. Ltd

HLB Pharmaceutical Co., Ltd. is a South Korean company that researches and develops peptide drugs. It offers a wide range of pharmaceutical products, including skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensives, pain relievers, anti-inflammatories, metabolic drugs, ophthalmic agents, local anesthetics, antidiabetics, chemotherapeutics, antibiotics, and various other treatments. The company is also developing CTT-004 for ataxia induced by spinocerebellar degeneration and provides CMO services. Formerly known as Mediforum Pharmaceutical Incorporation, it changed its name to HLB Pharmaceutical Co., Ltd. in October 2020. Founded in 1998, it is headquartered in Namyangju-si, South Korea.